Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06737354 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).

StatusEnrolling by Invitation
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Active, Not Recruiting to Enrolling by Invitation
    • Start date: Dec 5, 2024 to Apr 22, 2025
    v3
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the safety and efficacy of IVB103 injection in subjects with nAMD.
Trial Details
NCT Number NCT06737354
Lead Sponsor InnoVec Biotherapeutics Inc.
Collaborators: NeoVec Biotherapeutics Inc.
Conditions
(from sponsor)		 nAMD
Related terms Retinal Diseases
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov